baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BNP Paribas Discount Zert 6MK 24..../ DE000PC56UK8 /

1/23/2025 9:35:28 AM	Chg.-0.17	Bid10:00:31 PM	Ask10:00:31 PM	Underlying	Strike price	Expiration date	Option type
85.36EUR	-0.20%	- Bid Size: -	- Ask Size: -	MERCK CO. D...	- -	6/24/2026	Call

TeleTrader 10/31/2024 Merck's Q3 sales up 4% to $16.7 billion

GlobeNewswire 7/31/2024 Vaccinex Reports Positive Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease

TeleTrader 7/30/2024 Merck falls 7% after Q2 earnings report

TeleTrader 7/30/2024 Merck's Q2 sales up 7% to $16.1 billion

GlobeNewswire 7/17/2024 Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease a...

GlobeNewswire 7/9/2024 Prelude Therapeutics Announces Clinical Collaboration with Merck to Evaluate PRT3789 in Combination ...

GlobeNewswire 6/27/2024 Verizon elects Caroline A. Litchfield to its Board of Directors

GlobeNewswire 6/27/2024 Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product

GlobeNewswire 6/25/2024 Qure.ai announces strategic investment by Merck Global Health Innovation Fund to boost innovation of...

GlobeNewswire 6/18/2024 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...

GlobeNewswire 6/6/2024 Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...

GlobeNewswire 6/5/2024 Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors

GlobeNewswire 6/3/2024 Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, ...

TeleTrader 5/29/2024 Merck to buy biotech firm EyeBio for up to $3B

GlobeNewswire 5/29/2024 Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...

GlobeNewswire 5/29/2024 Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study

GlobeNewswire 5/7/2024 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...

GlobeNewswire 5/6/2024 Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...

GlobeNewswire 5/2/2024 Cerevance Achieves First Milestone in Research Collaboration with Merck

TeleTrader 4/25/2024 Merck's Q1 sales rise by 9% to $15.8 billion

GlobeNewswire 4/2/2024 Vaccinex Reports 2023 Financial Results and Provides Corporate Update

GlobeNewswire 3/6/2024 IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Can...

GlobeNewswire 3/4/2024 C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...

TeleTrader 2/2/2024 Merck Group to expand investment in South Korea

TeleTrader 2/1/2024 Merck's Q4 sales up 6% to $14.6B

BNP Paribas Discount Zert 6MK 24..../ DE000PC56UK8 /

If you wish to receive reply to your feedback, please provide your email address.